Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART)
Author Information
Author(s): S. Dische, M.I. Saunders
Primary Institution: Marie Curie Research Wing, Regional Radiotherapy and Oncology Centre, Mount Vernon Hospital
Hypothesis
Can continuous, hyperfractionated, accelerated radiotherapy improve tumor control and reduce treatment duration?
Conclusion
The CHART method shows promise in improving tumor control and survival rates in patients with advanced cancers.
Supporting Evidence
- 92% of patients with primary tumors showed complete regression.
- 42% of patients with locally advanced carcinoma of the bronchus had complete radiological disappearance of the tumor.
Takeaway
This study looks at a new way to give radiation treatment that might help more people with cancer get better faster.
Methodology
Patients received radiotherapy three times daily for 12 days with varying doses.
Potential Biases
Potential biases due to the non-randomized nature of the pilot study.
Limitations
The study was a pilot and may not represent larger populations.
Participant Demographics
Included patients with advanced squamous cell cancer in the head and neck region.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website